Cartesian Therapeutics, Inc. (RNAC)
USD 16.92
(-7.59%)
USD 16.92
(-7.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -51.16 Million | -31.63 Million | -60.38 Million | 34.88 Million | -51.43 Million | -59.16 Million |
| Net Income | -219.71 Million | 35.37 Million | -25.68 Million | -68.87 Million | -55.35 Million | -65.33 Million |
| Depreciation & Amortization | 843 Thousand | 1.28 Million | 1.25 Million | 734 Thousand | 2.02 Million | 975 Thousand |
| Deferred income taxes | -19 Million | -21.4 Million | 2.39 Million | 10.85 Million | - | - |
| Stock-based compensation | 22.52 Million | 11.19 Million | 7.72 Million | 5.42 Million | - | - |
| Change in working capital | 4.97 Million | -60.37 Million | -48.19 Million | 85 Million | -4.48 Million | -781 Thousand |
| Other non-cash items | 159.21 Million | 2.29 Million | 2.13 Million | 1.74 Million | 16.02 Million | 8.44 Million |
| Investing Cash Flow | 34.6 Million | -15 Million | -17.14 Million | -741 Thousand | 229 Thousand | 25.27 Million |
| Investments in PPE | -206 Thousand | -1.2 Million | -1.08 Million | -815 Thousand | -47 Thousand | -884 Thousand |
| Acquisitions | 6.56 Million | - | - | 74 Thousand | 122 Thousand | 99 Thousand |
| Investment purchases | - | -33.5 Million | -32.45 Million | - | -18.18 Million | -15.59 Million |
| Sales/Maturities of investments | 28.25 Million | 19.7 Million | 16.4 Million | - | 18.34 Million | 41.65 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -13.14 Million | 39.21 Million | 52.89 Million | 14.43 Million | 105.04 Million | 697 Thousand |
| Debt repayment | -27.45 Million | - | - | -19.31 Million | -2.8 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -6.16 Million | - | - | - | - | - |
| Common Stock Issuance | 14.31 Million | 38.98 Million | 51.95 Million | 12.37 Million | 107.84 Million | 697 Thousand |
| Other Financing Activities | 231 Thousand | -110 Thousand | - | -4.72 Million | - | - |
| Accounts receivables | 726 Thousand | 3.31 Million | -2.69 Million | -2.22 Million | -5 Million | - |
| Accounts payables | 2.83 Million | 92 Thousand | -219 Thousand | -57 Thousand | -600 Thousand | -516 Thousand |
| Inventory | -3.84 Million | 920 Thousand | 211 Thousand | -7.17 Million | - | - |
| Other working capital | 5.25 Million | -64.7 Million | -45.49 Million | 94.46 Million | 1.11 Million | -265 Thousand |
| Cash at beginning of period | 108.03 Million | 115.43 Million | 140.06 Million | 91.55 Million | 37.4 Million | 70.69 Million |
| Cash at end of period | 78.28 Million | 108.03 Million | 115.43 Million | 140.06 Million | 90.17 Million | 37.4 Million |
| Capital Expenditure | -206 Thousand | -1.2 Million | -1.08 Million | -815 Thousand | -47 Thousand | -884 Thousand |
| Effect of forex changes on cash | -53 Thousand | 20 Thousand | -3000.00 | -58 Thousand | -1.06 Million | - |
| Net cash flow / Change in cash | -29.75 Million | -7.39 Million | -24.62 Million | 48.51 Million | 52.76 Million | -33.29 Million |
| Free Cash Flow | -51.36 Million | -32.83 Million | -61.46 Million | 34.06 Million | -51.48 Million | -60.04 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -56.82 Million | -219.71 Million | -177.65 Million | -9 Million | -11.38 Million | -21.66 Million |
| Depreciation & Amortization | 183 Thousand | 843 Thousand | 272 Thousand | 189 Thousand | 176 Thousand | 206 Thousand |
| Deferred income taxes | - | -19 Million | 125.09 Million | -3.04 Million | -6.34 Million | 4 Million |
| Stock-based compensation | 1.43 Million | 22.52 Million | 14.14 Million | 2.32 Million | 3.78 Million | 2.27 Million |
| Change in working capital | -6.36 Million | 4.97 Million | -3.91 Million | -34 Thousand | 3.31 Million | 5.6 Million |
| Other non-cash items | 43.61 Million | 159.21 Million | 18.77 Million | 358 Thousand | 561 Thousand | 814 Thousand |
| Investing Cash Flow | -602 Thousand | 34.6 Million | 6.49 Million | - | -12 Thousand | 28.12 Million |
| Investments in PPE | -602 Thousand | -206 Thousand | -64 Thousand | - | -12 Thousand | -130 Thousand |
| Acquisitions | - | 6.56 Million | 6.56 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 28.25 Million | - | - | - | 28.25 Million |
| Other Investing Activities | - | - | 6.56 Million | - | - | - |
| Financing Cash Flow | 43.03 Million | -13.14 Million | 14.08 Million | -24.78 Million | -2.58 Million | 149 Thousand |
| Debt repayment | - | -27.45 Million | - | -24.87 Million | -2.58 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -6.16 Million | - | - | - | - |
| Common Stock Issuance | 43.03 Million | 14.31 Million | 14.08 Million | 82 Thousand | - | 149 Thousand |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 4.47 Million | 726 Thousand | -972 Thousand | 487 Thousand | 1.45 Million | -243 Thousand |
| Accounts payables | -633 Thousand | 2.83 Million | 2.79 Million | 85 Thousand | -796 Thousand | 747 Thousand |
| Inventory | - | -3.84 Million | -3.46 Million | 370 Thousand | 3.3 Million | -4.06 Million |
| Other working capital | -10.21 Million | 5.25 Million | -2.27 Million | -976 Thousand | -654 Thousand | 9.15 Million |
| Cash at beginning of period | 76.91 Million | 108.03 Million | 80.98 Million | 115 Million | 127.52 Million | 108.03 Million |
| Cash at end of period | 103.41 Million | 78.28 Million | 78.28 Million | 80.98 Million | 115 Million | 127.52 Million |
| Capital Expenditure | -602 Thousand | -206 Thousand | -64 Thousand | - | -12 Thousand | -130 Thousand |
| Effect of forex changes on cash | -5000.00 | -53 Thousand | 16 Thousand | -20 Thousand | -28 Thousand | -21 Thousand |
| Net cash flow / Change in cash | 26.5 Million | -29.75 Million | -2.69 Million | -34.02 Million | -12.52 Million | 19.48 Million |
| Free Cash Flow | -16.51 Million | -51.36 Million | -23.35 Million | -9.21 Million | -9.9 Million | -8.89 Million |
CHH
GAEX
8176
SDY
UREKA
UBIS